PR Domain Containing 9 (PRDM9) (Middle Region) Peptid
PRDM9
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle PRDM9 Produkte
- PRDM9 (PR Domain Containing 9 (PRDM9))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PRDM9 antibody (Catalog #: ARP35967_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PRDM9 (PR Domain Containing 9 (PRDM9))
- Hintergrund
-
The PR domain is a protein-protein interaction module of about 100 amino acids. PR domain-containing proteins, such as PRDM9, are often involved in transcriptional regulation.The PR domain is a protein-protein interaction module of about 100 amino acids. PR domain-containing proteins, such as PRDM9, are often involved in transcriptional regulation (Jiang and Huang, 2000 [PubMed 10668202]).[supplied by OMIM].
Alias Symbols: PFM6, MSBP3, PRMD9, ZNF899, MEISETZ
Protein Size: 894 - Molekulargewicht
- 103 kDa
- Gen-ID
- 56979
- NCBI Accession
- NM_020227, NP_064612
- UniProt
- Q9NQV7
-
Sie sind hier:
